serpin family G member 1
Last updated 11 Mar 2024
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The SERPING1 gene provides instructions for making a protein called C1 inhibitor (C1-INH), which is a type of serine protease inhibitor (serpin). Serpins help control several types of chemical reactions by blocking the activity of certain proteins. C1-INH is important for controlling a range of processes involved in maintaining blood vessels, including inflammation. Inflammation is a normal body response to infection, irritation, or injury.
Video picks for GenesVideo library
Normal function
The SERPING1 gene provides instructions for making a protein called C1 inhibitor (C1-INH), which is a type of serine protease inhibitor (serpin). Serpins help control several types of chemical reactions by blocking the activity of certain proteins. C1-INH is important for controlling a range of processes involved in maintaining blood vessels, including inflammation. Inflammation is a normal body response to infection, irritation, or injury.
C1-INH blocks the activity of several proteins in the blood, including plasma kallikrein and the activated form of factor XII (called factor XIIa). These two proteins are involved in the production of bradykinin. Bradykinin is a protein fragment (peptide) that promotes inflammation by allowing fluids to leak through blood vessel walls into body tissues (vascular permeability). C1-INH attaches (binds) to plasma kallikrein and factor XIIa, which prevents them from completing any further reactions. These proteins are cleared from the bloodstream once they are bound to C1-INH.
Conditions referring to this gene or chromosome
Other names
C1-INH
C1IN
C1INH
C1NH
complement component 1 inhibitor
IC1_HUMAN
plasma protease C1 inhibitor
serine/cysteine proteinase inhibitor clade G member 1
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
Patient picks for Genes

Mental health
Not quite 'back to normal': a guide to post-pandemic family healing
When news broke in late 2019 of a virus spreading rapidly across the globe, the word ‘unprecedented’ quickly became part of everyday vocabulary in the months that followed. The outbreak of Covid-19 marked the world’s most significant public health crisis in at least a century, shaking the foundations of the one place we usually feel most secure - the home. It is no surprise that years of disrupted routines have left a lasting mark on the family unit. From the sudden loss of support networks to the blurring of boundaries between home, school, and work, the pandemic reshaped how families function. We spoke with a psychotherapist to explore these long-term psychological ripples and why reflecting on that period is essential for understanding - and healing - the family dynamic today.
by Victoria Raw

Podcasts
The parental minefield
How often have you said something quite ordinary to a parent, or they’ve said something to you and suddenly the room feels like it’s about to explode? Welcome to the parental nightmare. It’s not just about conflict, it’s about what’s hidden underneath these relationships – family secrets, unspoken stories, patterns of behaviour passed from one generation to the next. In this episode Clare and Aileen explore the complex, often lifelong, relationship we have with our parents and discuss practical strategies to help you navigate this important relationship.
by Thomas Andrew Porteus, MBCS

Podcasts
What are relationships anyway?
Relationships – what are they? We often think of relationships as intimate with a partner and yet we actually have hundreds of relationships with friends, family, at work, at play even with nature and beyond. Clare and Aileen kick off the season by discussing the breadth of relationships.
by Thomas Andrew Porteus, MBCS

COVID-19
How to meet friends and family safely outdoors
Across the UK, lockdowns are easing and we're allowed to see friends and family outside (and indoors too if you live in England or Scotland). But that doesn't mean the risk of spreading COVID-19 has vanished; you still need to take precautions to keep yourself and your loved ones safe.
by Andrea Downey

COVID-19
COVID-19: how to support vulnerable friends and family during the coronavirus pandemic
Current coronavirus lockdown measures are especially challenging for older people and those with mental health issues and underlying health conditions. We look at how to support vulnerable loved ones during the COVID-19 pandemic.
by Sally Turner

Sexual health
Natural family planning methods
Natural family planning is a method of preventing pregnancy that does not involve medicines or devices. The fertility awareness method is a type of natural family planning that involves being able to predict your fertile time. This is the time you are likely to conceive.
by Dr Jacqueline Payne, FRCGP
Related patient information and medicines

Patient information leaflet
Can I take Fenofibrate and Gabapentin together?
There are no known significant interactions between fenofibrate and gabapentin. These two medicines work in different ways and are processed by different organs in the body. Why this happens Fenofibrate is primarily broken down by the liver and affects blood fats (lipids). Gabapentin is not metabolised by the liver; it is filtered out of the body.

Patient information leaflet
Breast cancer in men
Men can get cancer of the breast becau... Certain things can make the condition more likely, such as: Age. Breast cancer in men tends to develop in older men, usually between the ages of 60 and 70. Family history. Some breast cancers are caused by a flawed gene. The main gene which can cause men to be more at risk of breast cancer is the BRCA2.

Patient information leaflet
Muscular dystrophy
Muscular dystrophy is an inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. The different types also vary as to what age they begin. What is muscular dystrophy. Muscular dystrophy (MD) is the name given to a group of.

Patient information leaflet
Breast cancer facts and risk factors
What are the risk factors for breast cancer. Dr Sarah Jarvis MBE Although breast cancer can develop for no apparent reason, there are certain risk factors which increase the chance that breast cancer will develop. [https://patient.info/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Most cases of breast cancer.

Patient information leaflet
Glaucoma
Family d... Glaucoma is rare at the age of 40, only affecting about 1 in 300 people. By the age of 70, about 1 in 33 people in the UK have glaucoma. Glaucoma is unusual in people under the age of 35. Glaucoma can affect anyone but it is more common if you: Have a family history of glaucoma (if a parent, brother or sister has glaucoma, you are 2-4.

Patient information leaflet
Huntington's disease
If you know that you have a family history of Huntington's disease, make sure that you mention that at the appointment. What causes Huntington's disease. Huntington's disease is caused by a defective gene that you inherit from your parents. Huntington's disease is an autosomal dominant condition, meaning you can inherit the disease from just one.
Further reading and references
- serpin family G member 1; MedlinePlus, National Library of Medicine.
- Busse PJ, Christiansen SC, Riedl MA, Banerji A, Bernstein JA, Castaldo AJ, Craig T, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Zuraw BL. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 Jan;9(1):132-150.e3. doi: 10.1016/j.jaip.2020.08.046. Epub 2020 Sep 6.
- Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009 Feb;15(2):69-78. doi: 10.1016/j.molmed.2008.12.001. Epub 2009 Jan 21.
- Gosswein T, Kocot A, Emmert G, Kreuz W, Martinez-Saguer I, Aygoren-Pursun E, Rusicke E, Bork K, Oldenburg J, Muller CR. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema. Cytogenet Genome Res. 2008;121(3-4):181-8. doi: 10.1159/000138883. Epub 2008 Aug 28.
- Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M. Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. Mol Immunol. 2008 Aug;45(13):3536-44. doi: 10.1016/j.molimm.2008.05.007. Epub 2008 Jun 30.
- Sinnathamby ES, Issa PP, Roberts L, Norwood H, Malone K, Vemulapalli H, Ahmadzadeh S, Cornett EM, Shekoohi S, Kaye AD. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology. Adv Ther. 2023 Mar;40(3):814-827. doi: 10.1007/s12325-022-02401-0. Epub 2023 Jan 7.
- Veronez CL, Csuka D, Sheikh FR, Zuraw BL, Farkas H, Bork K. The Expanding Spectrum of Mutations in Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2229-2234. doi: 10.1016/j.jaip.2021.03.008. Epub 2021 Mar 19.
- Wouters D, Wagenaar-Bos I, van Ham M, Zeerleder S. C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opin Biol Ther. 2008 Aug;8(8):1225-40. doi: 10.1517/14712598.8.8.1225.
- Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008 Sep 4;359(10):1027-36. doi: 10.1056/NEJMcp0803977. No abstract available.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

